Plain-English translation of NCT07224490 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
Researchers are studying how a hormone called kisspeptin affects the reproductive system's brain control center. This trial will give participants a single injection of kisspeptin and then take frequent blood samples to measure how the body responds. The study aims to understand how this hormone messenger works in both healthy people and those with long COVID.
Kisspeptin plays a crucial role in controlling reproductive hormones, but scientists don't fully understand how it works in people with long COVID or other reproductive disorders. This research could help explain why some people experience reproductive problems and guide future treatments.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would visit the study site for one appointment lasting 1โ2 hours. During your visit, researchers will give you a single injection of kisspeptin and then take blood samples every 10 minutes to measure how your body responds. The study involves one day of participation, making it a straightforward way to contribute to understanding how this hormone works.
AI-generated summary from trial data ยท Jun 9, 2026 ยท Not medical advice
United States